Pasha Sarraf
Director at Cue Biopharma, Inc. (CUE)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-46.6%
vs. S&P 500-42.8%
Beat the market0%
Paper profit on buys+$8.9M
Total bought / sold$100K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 2SEC | CUECue Biopharma, Inc. | Buy | 4,229new position | $0.31 | $1K | +8822.6% |
| Jan 2SEC | CUECue Biopharma, Inc. | Buy | 77,14881,377 held (+1824%) | $0.30 | $23K | +9120.0% |
| Jan 2SEC | CUECue Biopharma, Inc. | Buy | 86,947168,324 held (+107%) | $0.32 | $28K | +8543.8% |
| Jan 2SEC | CUECue Biopharma, Inc. | Buy | 78,116246,440 held (+46%) | $0.31 | $24K | +8822.6% |
| Jan 2SEC | CUECue Biopharma, Inc. | Buy | 77,417323,857 held (+31%) | $0.30 | $23K | +9120.0% |
- Buy
Director Pasha Sarraf bought $1K of CUE at $0.31 — first open-market purchase in our records; opens a new position.
- Buy
Director Pasha Sarraf bought $23K of CUE at $0.30 — largest purchase by this insider in our records; raises the stake by 1824%.
- Buy
Director Pasha Sarraf bought $28K of CUE at $0.32 — largest purchase by this insider in our records; raises the stake by 107%.
- Buy
Director Pasha Sarraf bought $24K of CUE at $0.31 — raises the stake by 46%.
- Buy
Director Pasha Sarraf bought $23K of CUE at $0.30 — raises the stake by 31%.